Bullfrog AI Holdings (Bullfrog AI Holdings) Momentum Rank : 0 (As of Jun. 06, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Bullfrog AI Holdings Momentum Rank?

Bullfrog AI Holdings has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Bullfrog AI Holdings Momentum Rank Related Terms

Thank you for viewing the detailed overview of Bullfrog AI Holdings's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Bullfrog AI Holdings (Bullfrog AI Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bullfrog AI Holdings Inc (NAS:BFRG) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

325 Ellington Boulevard, Unit 317, Gaithersburg, MD, USA, 20878

Website

https://www.bullfrogai.com

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

Executives

William Enright	director	910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG MD 20878
R Don Elsey	director	2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850
Dane R Saglio	officer: Chief Financial Officer
Jason David Hanson	director	8125 NORTH HAYDEN ROAD, SCOTTSDALE AZ 85258-2463
Vininder Singh	director, 10 percent owner, officer: Chief Executive Officer	4 BLACK KETTLE COURT, BOYDS MD 20841